Teladoc Health Inc (TDOC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -428,793 | -417,808 | -333,468 | -199,649 | -485,136 |
| Depreciation Amortization | 280,874 | 209,435 | 140,087 | 69,260 | 123,383 |
| Income taxes - deferred | 41,800 | 91,414 | 83,823 | 87,004 | -90,158 |
| Accounts receivable | -11,172 | -19,407 | -16,573 | -11,717 | -21,091 |
| Accounts payable and accrued liabilities | 1,188 | -11,115 | -4,741 | -11,989 | -87,995 |
| Other Working Capital | -43,986 | -59,351 | -66,974 | -69,660 | -90,483 |
| Other Operating Activity | 354,079 | 317,614 | 232,037 | 118,725 | 597,969 |
| Operating Cash Flow | $193,990 | $110,782 | $34,191 | $-18,026 | $-53,511 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 50,000 | 10,901 | 10,901 | 50,000 | 2,496 |
| PPE Investments | -63,934 | -41,013 | -25,913 | -13,259 | -26,042 |
| Net Acquisitions | -78,663 | -75,944 | -56,336 | -55,921 | -567,429 |
| Purchase Of Investment | 10,901 | 50,000 | 50,000 | N/A | N/A |
| Other Investing Activity | 8,715 | 3,150 | 3,150 | 3,150 | 0 |
| Investing Cash Flow | $-72,981 | $-52,906 | $-18,198 | $-16,030 | $-590,975 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 1,091,659 |
| Debt Repayment | N/A | -139 | N/A | -130 | -238,153 |
| Common Stock Issued | 42,591 | 36,952 | 28,812 | 20,556 | 59,036 |
| Common Stock Repurchased | N/A | N/A | -137 | N/A | N/A |
| Other Financing Activity | -1,644 | -2,491 | 4,863 | 1,749 | -53,406 |
| Financing Cash Flow | $40,947 | $34,322 | $33,538 | $22,175 | $859,136 |
| Exchange Rate Effect | -1,800 | -1,694 | 869 | -1,339 | 4,321 |
| Beginning Cash Position | 733,324 | 733,324 | 733,324 | 733,324 | 514,353 |
| End Cash Position | 893,480 | 823,828 | 783,724 | 720,104 | 733,324 |
| Net Cash Flow | $160,156 | $90,504 | $50,400 | $-13,220 | $218,971 |
| Free Cash Flow | |||||
| Operating Cash Flow | 193,990 | 110,782 | 34,191 | -18,026 | -53,511 |
| Capital Expenditure | -63,934 | -41,013 | -25,913 | -13,259 | -26,042 |
| Free Cash Flow | 130,056 | 69,769 | 8,278 | -31,285 | -79,553 |